Synthetic psychoactive drugs have become a serious public health threat in recent years. This is particularly true of the fentanyls, a large family of synthetic opioids, which can be up to 10,000 times more potent than morphine. Synthetic opioids are highly addictive and, because of their potency, often prove fatal: among the roughly 72,000 drug overdose deaths in the US in 2017, some 30,000 were related to synthetic opioids.
But researchers at The Scripps Research Institute have created monoclonal antibodies–made by identical immune cells–that are effective against several synthetic opioids, including fentanyl and the deadliest of the fentanyls, carfentanil. Their findings could both combat opioid addiction as well as reduce overdose deaths.
The study looked at the efficacy of vaccines containing the newly developed opioid antibodies in animals. The team, led by Kim Janda, tested the antibodies using a common pain response challenge, in which a heated beam of light is applied to a mouse’s tail. The time it takes for the mouse to withdraw its tail is measured: quick reactions suggest the animal is feeling pain, whereas a longer response suggests that pain response has been muted.
Mice that were given opioids such as fentanyl or carfentanil without the antibody exhibited a big reduction in tail withdrawal, suggesting they could not sense the pain. When they were given the opioid-blocking antibody, tail withdrawal was normalized, suggesting that the vaccine blocked the analgesic effects of the drug.
The researchers then tested whether the vaccine could prevent against lethal overdose. In mice administered the vaccine followed by a dose of fentanyl that was fatal in non-vaccinated animals. All the vaccinated mice were protected from overdose.
The antibodies were also effective against other forms of fentanyl, including carfentanil and seven other analogs, in both pain tests and lethality studies.
Janda’s team has begun to develop human antibodies to synthetic opioids, and will test their efficacy in the future. “When it comes to the very powerful opioid carfentanil the current treatment for this opioid’s induced lethality does not work very well–it has no staying power,” says Janda. “Antibodies persist longer, and thus have enormous promise for addressing both opioid addiction as well as overdose.”
A synthetic opioid vaccine might also be used as a prophylactic measure to protect people at risk of coming into contact with the drugs, such as first responders, who have occasionally overdosed by inhaling tiny quantities of fentanyl. “These antibodies could be used to protect police, EMTs, and other first responders from inadvertent acute fentanyl exposure,” says Janda. “A canine version might even one day be used to protect drug-sniffing dogs.”
Learn more: Vaccine could help address the opioid epidemic
The Latest on: Opioid epidemic
via Google News
The Latest on: Opioid epidemic
- How A Small-City West Virginia Lawyer Became One Of The Attorneys Leading National Opioids Lawsuiton October 15, 2019 at 5:36 am
But those on the front lines of the opioid epidemic are already looking beyond the courtroom to the massive settlement they expect will ultimately resolve the case. Experts have little doubt it would ...
- Healthpointe Implements Chronic Pain Programs to Fight Opioid Epidemicon October 15, 2019 at 3:00 am
LA MIRADA, Calif, Oct. 15, 2019 /PRNewswire-PRWeb/ -- Healthpointe, a premiere multidisciplinary healthcare organization in Southern California, is taking a major lead in fighting the opioid epidemic.
- Western Michigan University professor testing opioid treatment appon October 15, 2019 at 2:51 am
This is the first time the technology platform will be used in emergency departments to engage patients upon reversal from acute opioid overdose. "WMU is situated in a region of the U.S. that is being ...
- Mashantuckets filed federal suit against Purdue Pharma, others over opioid epidemicon October 14, 2019 at 5:57 pm
the painkiller whose misuse allegedly has contributed to the national epidemic of opioid overdose deaths and addictions. Also among those named are manufacturers Cephalon, Endo, Allergan and ...
- MU grant will expand outreach to communities affected by opioid epidemicon October 14, 2019 at 4:34 pm
A $1.2 million federal grant will expand an MU Graduate Psychology Education program which trains psychology interns to help underserved communities battle the opioid epidemic. Laura Schopp, chair and ...
- Opioid epidemic shifts from prescription painkillers to street drugson October 14, 2019 at 8:41 am
When it comes to public health threats, the third wave with mounting deaths from fentanyl and its ilk is the opioid epidemic’s new form. But that doesn’t mean the original problem with prescription ...
- Maine Voices: Establish pain management medical center to help control opioid epidemicon October 13, 2019 at 1:32 am
Fully aware of the opioid epidemic and its particular impact in the state of Maine, I am impressed by efforts at the state level to curb the damage, enhancing education, supervising and monitoring ...
- 'Sesame Street' Is Tackling the Opioid Epidemic, But There's Some Bad Newson October 10, 2019 at 5:03 pm
but we wish they would try to ensure more of the 5.7 million kids under 11 who live in a home with a parent who has substance abuse issues actually see these great videos. The post ‘Sesame Street’ Is ...
- Governor's opioid task force holds second meeting, prepares recommendations for combatting epidemicon October 9, 2019 at 4:07 pm
Governor Little's opioid task force held their second meeting Wednesday, continuing their efforts to end the opioid epidemic in Idaho.
via Bing News